Filing Details

Accession Number:
0001193125-20-038091
Form Type:
13G Filing
Publication Date:
2020-02-14 15:56:33
Filed By:
Anson Funds Management Lp
Company:
Kintara Therapeutics Inc. (NASDAQ:KTRA)
Filing Date:
2020-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Anson Funds Management 0 290,125 0 290,125 290,125 1.5%
Anson Management GP 0 290,125 0 290,125 290,125 1.5%
Bruce R. Winson 0 290,125 0 290,125 290,125 1.5%
Anson Advisors Inc 0 290,125 0 290,125 290,125 1.5%
Amin Nathoo 0 290,125 0 290,125 290,125 1.5%
Moez Kassam 0 290,125 0 290,125 290,125 1.5%
Filing

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 13G/A

(Rule 13d-102)

(Amendment No. 1)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

 

 

DelMar Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

247078306

(CUSIP Number)

December 31, 2019

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒  Rule 13d-1(b)

☐  Rule 13d-1(c)

☐  Rule 13d-1(d)

 

 

 


CUSIP No. 247078306   13G/A   

 

  1      

  NAME OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Anson Funds Management LP

  2      

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

  (a)  ☐

  (b)  ☐

 

  3      

  SEC USE ONLY

 

  4      

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Texas

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

     5      

  SOLE VOTING POWER

 

  0

  6      

  SHARED VOTING POWER

 

  290,125

  7      

  SOLE DISPOSITIVE POWER

 

  0

  8      

  SHARED DISPOSITIVE POWER

 

  290,125

  9      

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  290,125

10      

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11      

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  1.5% **

12      

  TYPE OF REPORTING PERSON*

 

  IA, PN

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

2


CUSIP No. 247078306   13G/A   

 

  1      

  NAME OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Anson Management GP LLC

  2      

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

  (a)  ☐

  (b)  ☐

 

  3      

  SEC USE ONLY

 

  4      

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Texas

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

     5      

  SOLE VOTING POWER

 

  0

  6      

  SHARED VOTING POWER

 

  290,125

  7      

  SOLE DISPOSITIVE POWER

 

  0

  8      

  SHARED DISPOSITIVE POWER

 

  290,125

  9      

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  290,125

10      

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11      

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  1.5% **

12      

  TYPE OF REPORTING PERSON*

 

  HC, OO

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

3


CUSIP No. 247078306   13G/A   

 

  1      

  NAME OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Bruce R. Winson

  2      

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

  (a)  ☐

  (b)  ☐

 

  3      

  SEC USE ONLY

 

  4      

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States Citizen

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

     5      

  SOLE VOTING POWER

 

  0

  6      

  SHARED VOTING POWER

 

  290,125

  7      

  SOLE DISPOSITIVE POWER

 

  0

  8      

  SHARED DISPOSITIVE POWER

 

  290,125

  9      

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  290,125

10      

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11      

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  1.5% **

12      

  TYPE OF REPORTING PERSON*

 

  HC, IN

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

4


CUSIP No. 247078306   13G/A   

 

  1      

  NAME OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Anson Advisors Inc.

  2      

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

  (a)  ☐

  (b)  ☐

 

  3      

  SEC USE ONLY

 

  4      

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Ontario, Canada

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

     5      

  SOLE VOTING POWER

 

  0

  6      

  SHARED VOTING POWER

 

  290,125

  7      

  SOLE DISPOSITIVE POWER

 

  0

  8      

  SHARED DISPOSITIVE POWER

 

  290,125

  9      

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  290,125

10      

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11      

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  1.5% **

12      

  TYPE OF REPORTING PERSON*

 

  FI, CO

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

5


CUSIP No. 247078306   13G/A   

 

  1      

  NAME OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Amin Nathoo

  2      

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

  (a)  ☐

  (b)  ☐

 

  3      

  SEC USE ONLY

 

  4      

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Canadian Citizen

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

     5      

  SOLE VOTING POWER

 

  0

  6      

  SHARED VOTING POWER

 

  290,125

  7      

  SOLE DISPOSITIVE POWER

 

  0

  8      

  SHARED DISPOSITIVE POWER

 

  290,125

  9      

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  290,125

10      

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11      

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  1.5% **

12      

  TYPE OF REPORTING PERSON*

 

  HC, IN

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

6


CUSIP No. 247078306   13G/A   

 

  1      

  NAME OF REPORTING PERSONS

  I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Moez Kassam

  2      

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

  (a)  ☐

  (b)  ☐

 

  3      

  SEC USE ONLY

 

  4      

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Canadian Citizen

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

     5      

  SOLE VOTING POWER

 

  0

  6      

  SHARED VOTING POWER

 

  290,125

  7      

  SOLE DISPOSITIVE POWER

 

  0

  8      

  SHARED DISPOSITIVE POWER

 

  290,125

  9      

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  290,125

10      

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  ☐

11      

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  1.5% **

12      

  TYPE OF REPORTING PERSON*

 

  HC, IN

 

*

SEE INSTRUCTIONS BEFORE FILLING OUT

**

SEE ITEM 4(b).

 

7


SCHEDULE 13G/A

This Amendment No. 1 (this Amendment) to Schedule 13G (the Schedule 13G) is being filed on behalf of Anson Funds Management LP (d/b/a Anson Funds), a Texas limited partnership, Anson Management GP LLC, a Texas limited liability company, Mr. Bruce R. Winson, the principal of Anson Funds Management LP and Anson Management GP LLC, Anson Advisors Inc., an Ontario, Canada corporation, Mr. Amin Nathoo, a director of Anson Advisors Inc., and Mr. Moez Kassam, a director of Anson Advisors Inc., relating to Common Stock, par value $0.001 per share (the Common Stock), of DelMar Pharmaceuticals, Inc., a Nevada corporation (the Issuer).

This Amendment relates to the Common Stock of the Issuer purchased by a private fund to which Anson Funds Management LP and Anson Advisors Inc. serve as co-investment advisors (the Fund). Anson Funds Management LP and Anson Advisors Inc. serve as co-investment advisors to the Fund and may direct the vote and disposition of the 290,125 shares of Common Stock held by the Fund. As the general partner of Anson Funds Management LP, Anson Management GP LLC may direct the vote and disposition of the 290,125 shares of Common Stock held by the Fund. As the principal of Anson Fund Management LP and Anson Management GP LLC, Mr. Winson may direct the vote and disposition of the 290,125 shares of Common Stock held by the Fund. As directors of Anson Advisors Inc., Mr. Nathoo and Mr. Kassam may each direct the vote and disposition of the 290,125 shares of Common Stock held by the Fund.

This Amendment amends and restates the Schedule 13G as set forth below.

 

Item 1(a)

Name of Issuer.

DelMar Pharmaceuticals, Inc.

 

Item 1(b)

Address of Issuers Principal Executive Offices.

Suite 720-999 West Broadway

Vancouver, BC, V5Z 1K5, Canada

 

Item 2(a)

Name of Person Filing.

Anson Funds Management LP, Anson Management GP LLC, Mr. Bruce R. Winson, Anson Advisors Inc., Mr. Amin Nathoo and Mr. Moez Kassam

 

Item 2(b)

Address of Principal Business Office, or, if none, Residence.

For Anson Funds Management LP, Anson Management GP LLC and Mr. Winson:

5950 Berkshire Lane, Suite 210

Dallas, Texas 75225

For Anson Advisors Inc., Mr. Nathoo and Mr. Kassam:

155 University Ave, Suite 207

Toronto, ON

M5H 3B7

 

8


Item 2(c)

Citizenship or Place of Organization.

Anson Funds Management LP is a limited partnership organized under the laws of the State of Texas. Anson Management GP LLC is a limited liability company organized under the laws of the State of Texas. Mr. Winson is a United States citizen. Anson Advisors Inc. is a corporation organized under the laws of Ontario, Canada. Mr. Nathoo and Mr. Kassam are each Canadian citizens.

 

Item 2(d)

Title of Class of Securities.

Common Stock, par value $0.001 per share.

 

Item 2(e)

CUSIP Number.

247078306

 

Item 3

Reporting Person.

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

 

(a)     Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)     Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)     Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d)     Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)     An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
(f)     An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
(g)     A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
(h)     A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
(i)     A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
(j)     A non-U.S. institution that is the functional equivalent of any of the institutions listed in § 240.13d-1 (b)(1)(ii)(A) through (I), so long as the non-U.S. institution is subject to a regulatory scheme that is substantially comparable to the regulatory scheme applicable to the equivalent U.S. institution.
(k)     Group, in accordance with §240.13d-1(b)(1)(ii)(K).

 

9


Item 4

Ownership.

 

  (a)

Anson Funds Management LP, Anson Management GP LLC, Mr. Winson, Anson Advisors Inc., Mr. Nathoo and Mr. Kassam are the beneficial owners of 290,125 shares of Common Stock held by the Fund. This amount consists of shares of Common Stock receivable by the Funds upon exercise of common warrants (the Common Warrants).

 

  (b)

Anson Funds Management LP, Anson Management GP LLC, Mr. Winson, Anson Advisors Inc., Mr. Nathoo and Mr. Kassam are the beneficial owners of 1.5% of the outstanding shares of Common Stock. This percentage is determined by dividing 290,125 by 19,360,138, which is the sum of: (i) 19,170,013 shares of Common Stock issued and outstanding, as reported in the Issuers prospectus on Form 424(b)(4) as filed with the Securities and Exchange Commission (the SEC) on November 21, 2019; and (ii) 290,125, the number of shares of Common Stock receivable by the Fund upon exercise of the Common Warrants.

 

  (c)

Anson Funds Management LP and Anson Advisors Inc., as the co-investment advisors to the Fund, may direct the vote and disposition of the 290,125 shares of Common Stock held by the Fund. Anson Management GP LLC, as the general partner of Anson Funds Management LP, may direct the vote and disposition of the 290,125 shares of Common Stock held by the Fund. As the principal of Anson Funds Management LP and Anson Management GP LLC, Mr. Winson may direct the vote and disposition of the 290,125 shares of Common Stock held by the Fund. Mr. Nathoo and Mr. Kassam, each as a director of Anson Advisors Inc., may direct the vote and disposition of the 290,125 shares of Common Stock held by the Fund.

 

Item 5

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the class of securities, check the following ☒.

 

Item 6

Ownership of More Than Five Percent on Behalf of Another Person.

Inapplicable.

 

Item 7

Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.

Inapplicable.

 

Item 8

Identification and Classification of Members of the Group.

Inapplicable.

 

Item 9

Notice of Dissolution of Group.

Inapplicable.

 

10


Item 10

Certification.

By signing below each of the Reporting Persons certifies that, to the best of such persons knowledge and belief, the securities referred to above were acquired and held in the ordinary course of business and were not acquired and were not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

11


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2020

 

ANSON FUNDS MANAGEMENT LP
By: Anson Management GP LLC, its general partner
By:  

/s/ Bruce R. Winson

  Bruce R. Winson
  Manager
ANSON MANAGEMENT GP LLC
By:  

/s/ Bruce R. Winson

  Bruce R. Winson
  Manager

/s/ Bruce R. Winson

Bruce R. Winson
ANSON ADVISORS INC.
By:  

/s/ Amin Nathoo

  Amin Nathoo
  Director
By:  

/s/ Moez Kassam

  Moez Kassam
  Director

/s/ Amin Nathoo

Amin Nathoo

/s/ Moez Kassam

Moez Kassam

 

12